Recruiting Pulmonary Embolism Studies in Huntersville
Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
This is a double-blind, placebo-controlled, randomized withdrawal, multicenter study of the efficacy and safety of FT218. FT218 drug product is a once-nightly formulation of sodium oxybate for extende...
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
Idiopathic Hypersomnia (IH) is a condition where people feel extremely sleepy during the day, especially in the morning, even if they sleep a lot at night. They may have trouble waking up in the morni...
About Pulmonary Embolism Clinical Trials in Huntersville
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Huntersville, NC. These studies are seeking a combined 190 participants. Research is being sponsored by Avadel, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Huntersville — FAQ
Are there pulmonary embolism clinical trials in Huntersville?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Huntersville, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Huntersville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntersville research site will contact you about next steps.
Are clinical trials in Huntersville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntersville studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Huntersville are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov